PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics

S Khan, Y He, X Zhang, Y Yuan, S Pu, Q Kong… - Oncogene, 2020 - nature.com
Abstract Using PROteolysis TArgeting Chimeras (PROTACs) to degrade proteins that are
important for tumorigenesis has emerged as a potential therapeutic strategy for cancer …
被引用次数：172 相关文章

PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics.

S Khan, Y He, X Zhang, Y Yuan, S Pu, Q Kong… - Oncogene, 2020 - go.gale.com
Using PROteolysis TArgeting Chimeras (PROTACs) to degrade proteins that are important
for tumorigenesis has emerged as a potential therapeutic strategy for cancer. PROTACs are …
[HTML] nih.gov

[HTML][HTML] PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics

S Khan, Y He, X Zhang, Y Yuan, S Pu, Q Kong… - Oncogene, 2020 - ncbi.nlm.nih.gov
Abstract Using PROteolysis TArgeting Chimeras (PROTACs) to degrade proteins that are
important for tumorigenesis has emerged as a potential therapeutic strategy for cancer …

PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics

S Khan, Y He, X Zhang, Y Yuan, S Pu, Q Kong… - …, 2020 - scholars.uthscsa.edu
Abstract Using PROteolysis TArgeting Chimeras (PROTACs) to degrade proteins that are
important for tumorigenesis has emerged as a potential therapeutic strategy for cancer …

PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics.

S Khan, Y He, X Zhang, Y Yuan, S Pu, Q Kong… - Oncogene, 2020 - europepmc.org
Abstract Using PROteolysis TArgeting Chimeras (PROTACs) to degrade proteins that are
important for tumorigenesis has emerged as a potential therapeutic strategy for cancer …

PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics

S Khan, Y He, X Zhang, Y Yuan, S Pu, Q Kong… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Using PROteolysis TArgeting Chimeras (PROTACs) to degrade proteins that are important
for tumorigenesis has emerged as a potential therapeutic strategy for cancer. PROTACs are …

PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics

S Khan, Y He, X Zhang, Y Yuan, S Pu, Q Kong… - Oncogene, 2020 - hero.epa.gov
Abstract Using PROteolysis TArgeting Chimeras (PROTACs) to degrade proteins that are
important for tumorigenesis has emerged as a potential therapeutic strategy for cancer …

[引用][C] PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics

S Khan, Y He, X Zhang, Y Yuan, S Pu, Q Kong… - Oncogene, 2020 - cir.nii.ac.jp
PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics.

S Khan, Y He, X Zhang, Y Yuan, S Pu, Q Kong… - Oncogene, 2020 - europepmc.org
Abstract Using PROteolysis TArgeting Chimeras (PROTACs) to degrade proteins that are
important for tumorigenesis has emerged as a potential therapeutic strategy for cancer …